PROCEPT BioRobotics (PRCT) Accounts Payables (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Accounts Payables data on file, last reported at $18.9 million in Q1 2026.

• Accounts Payables for Q1 2026 came in at $18.9 million, up 27.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.9 million (up 27.14% YoY), and the FY2025 annual result was $17.3 million, up 72.3% from the prior year.
• Accounts Payables improved to $18.9 million in Q1 2026 per PRCT's latest filing, from $17.3 million in the prior quarter.
• Over five years, Accounts Payables peaked at $18.9 million in Q1 2026 and troughed at $2.6 million in Q1 2022.
• A 5-year average of $11.1 million and a median of $10.3 million in 2023 frame the typical range for Accounts Payables.
• The sharpest annual moves came in 2022 and 2025: Accounts Payables soared 362.84% in 2022, then dropped 26.31% in 2025.
• A 5-year view of Accounts Payables shows it stood at $9.4 million in 2022, then surged by 43.74% to $13.5 million in 2023, then retreated by 25.68% to $10.0 million in 2024, then surged by 72.3% to $17.3 million in 2025, then rose by 9.06% to $18.9 million in 2026.
• Business Quant data shows PRCT's Accounts Payables at $18.9 million in Q1 2026, $17.3 million in Q4 2025, and $11.1 million in Q3 2025.